{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Thyroid Cancer: Treatment and Research Updates
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To present the latest information about genetic testing, diagnosis and treatment of thyroid cancer.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify potential controversies associated with genetic testing of thyroid nodules.
- Recognize factors that contribute to the over diagnosis of thyroid cancer.
- Identify findings from the first report of the whole genome sequencing of a papillary thyroid cancer.
Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$21.95
Credits:
- ANCC 2.4 CH
- DC - BON 2.4 CH
- FL - BON 2.0 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.--------------------------------------------------This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT0514
Published: May 2014
Expires: 1/1/2026
Sources:
Oncology Times
Required Passing Score: 11/15 (73%)